1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine

C239H337N37O — CID 159760802

IUPAC1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine
SMILESC.C.C.C.C1=Cc2ccccc2C1.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)c1cc2ccccc2cn1.c1cc2ccncc2cn1.c1cc2cnccc2cn1.c1cc2n(n1)CCNC2.c1ccc2[nH]ncc2c1.c1ccc2cnccc2c1.c1ccc2cnncc2c1.c1ccc2ncccc2c1.c1ccc2nccnc2c1.c1ccc2ncncc2c1.c1ccc2nnccc2c1.c1ccc2ocnc2c1.c1ccn2cnnc2c1.c1cn2cncc2cn1.c1cnc2cccnc2c1.c1cnc2ccncc2c1.c1cnc2ccncc2c1.c1cnc2cnccc2c1.c1cnc2ncccc2c1
InChIInChI=1S/C12H13N.2C9H7N.C9H8.11C8H6N2.C7H6N2.C7H5NO.C6H5N3.C6H9N3.C6H5N3.19C4H10.4CH4/c1-9(2)12-7-10-5-3-4-6-11(10)8-13-12;1-2-6-9-8(4-1)5-3-7-10-9;1-2-4-9-7-10-6-5-8(9)3-1;1-2-5-9-7-3-6-8(9)4-1;1-3-9-6-8-2-4-10-5-7(1)8;1-3-9-5-8-6-10-4-2-7(1)8;1-3-7-8(9-5-1)4-2-6-10-7;1-3-7-4-2-6-10-8(7)9-5-1;2*1-2-7-6-9-5-3-8(7)10-4-1;1-2-7-3-5-9-6-8(7)10-4-1;1-2-4-8-7(3-1)5-9-6-10-8;1-2-4-8-6-10-9-5-7(8)3-1;1-2-4-8-7(3-1)9-5-6-10-8;1-2-4-8-7(3-1)5-6-9-10-8;1-2-4-7-6(3-1)5-8-9-7;1-2-4-7-6(3-1)8-5-9-7;1-2-9-5-8-4-6(9)3-7-1;1-2-8-9-4-3-7-5-6(1)9;1-2-4-9-5-7-8-6(9)3-1;19*1-4(2)3;;;;/h3-9H,1-2H3;2*1-7H;1-6H,7H2;11*1-6H;1-5H,(H,8,9);2*1-5H;1-2,7H,3-5H2;1-5H;19*4H,1-3H3;4*1H4
InChIKeyNEVUPTAFICCHLV-UHFFFAOYSA-N
MW3744.58 g/mol
LogP66.98
Rot. Bonds1

About 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine

1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine (PubChem CID 159760802) has the molecular formula C239H337N37O and a molecular weight of 3744.58 g/mol. Its IUPAC name is 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine.

Molecular Properties

Compound Name1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine
PubChem CID159760802
Molecular FormulaC239H337N37O
Molecular Weight3744.58 g/mol
Exact Mass3741.75
IUPAC Name1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine
SMILESC.C.C.C.C1=Cc2ccccc2C1.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)c1cc2ccccc2cn1.c1cc2ccncc2cn1.c1cc2cnccc2cn1.c1cc2n(n1)CCNC2.c1ccc2[nH]ncc2c1.c1ccc2cnccc2c1.c1ccc2cnncc2c1.c1ccc2ncccc2c1.c1ccc2nccnc2c1.c1ccc2ncncc2c1.c1ccc2nnccc2c1.c1ccc2ocnc2c1.c1ccn2cnnc2c1.c1cn2cncc2cn1.c1cnc2cccnc2c1.c1cnc2ccncc2c1.c1cnc2ccncc2c1.c1cnc2cnccc2c1.c1cnc2ncccc2c1
InChIInChI=1S/C12H13N.2C9H7N.C9H8.11C8H6N2.C7H6N2.C7H5NO.C6H5N3.C6H9N3.C6H5N3.19C4H10.4CH4/c1-9(2)12-7-10-5-3-4-6-11(10)8-13-12;1-2-6-9-8(4-1)5-3-7-10-9;1-2-4-9-7-10-6-5-8(9)3-1;1-2-5-9-7-3-6-8(9)4-1;1-3-9-6-8-2-4-10-5-7(1)8;1-3-9-5-8-6-10-4-2-7(1)8;1-3-7-8(9-5-1)4-2-6-10-7;1-3-7-4-2-6-10-8(7)9-5-1;2*1-2-7-6-9-5-3-8(7)10-4-1;1-2-7-3-5-9-6-8(7)10-4-1;1-2-4-8-7(3-1)5-9-6-10-8;1-2-4-8-6-10-9-5-7(8)3-1;1-2-4-8-7(3-1)9-5-6-10-8;1-2-4-8-7(3-1)5-6-9-10-8;1-2-4-7-6(3-1)5-8-9-7;1-2-4-7-6(3-1)8-5-9-7;1-2-9-5-8-4-6(9)3-7-1;1-2-8-9-4-3-7-5-6(1)9;1-2-4-9-5-7-8-6(9)3-1;19*1-4(2)3;;;;/h3-9H,1-2H3;2*1-7H;1-6H,7H2;11*1-6H;1-5H,(H,8,9);2*1-5H;1-2,7H,3-5H2;1-5H;19*4H,1-3H3;4*1H4
InChIKeyNEVUPTAFICCHLV-UHFFFAOYSA-N
XLogP66.98
TPSA467.19 Ų
H-Bond Donors2
H-Bond Acceptors37
Rotatable Bonds1
Heavy Atoms277
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003744.58
LogP ≤ 566.98
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1037

Analyze 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine?
The IUPAC name of 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine (CID 159760802) is 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine.
What is the SMILES notation for 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine?
The canonical SMILES for 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine is C.C.C.C.C1=Cc2ccccc2C1.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)c1cc2ccccc2cn1.c1cc2ccncc2cn1.c1cc2cnccc2cn1.c1cc2n(n1)CCNC2.c1ccc2[nH]ncc2c1.c1ccc2cnccc2c1.c1ccc2cnncc2c1.c1ccc2ncccc2c1.c1ccc2nccnc2c1.c1ccc2ncncc2c1.c1ccc2nnccc2c1.c1ccc2ocnc2c1.c1ccn2cnnc2c1.c1cn2cncc2cn1.c1cnc2cccnc2c1.c1cnc2ccncc2c1.c1cnc2ccncc2c1.c1cnc2cnccc2c1.c1cnc2ncccc2c1.
What is the InChIKey of 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine?
The InChIKey is NEVUPTAFICCHLV-UHFFFAOYSA-N. The full InChI is InChI=1S/C12H13N.2C9H7N.C9H8.11C8H6N2.C7H6N2.C7H5NO.C6H5N3.C6H9N3.C6H5N3.19C4H10.4CH4/c1-9(2)12-7-10-5-3-4-6-11(10)8-13-12;1-2-6-9-8(4-1)5-3-7-10-9;1-2-4-9-7-10-6-5-8(9)3-1;1-2-5-9-7-3-6-8(9)4-1;1-3-9-6-8-2-4-10-5-7(1)8;1-3-9-5-8-6-10-4-2-7(1)8;1-3-7-8(9-5-1)4-2-6-10-7;1-3-7-4-2-6-10-8(7)9-5-1;2*1-2-7-6-9-5-3-8(7)10-4-1;1-2-7-3-5-9-6-8(7)10-4-1;1-2-4-8-7(3-1)5-9-6-10-8;1-2-4-8-6-10-9-5-7(8)3-1;1-2-4-8-7(3-1)9-5-6-10-8;1-2-4-8-7(3-1)5-6-9-10-8;1-2-4-7-6(3-1)5-8-9-7;1-2-4-7-6(3-1)8-5-9-7;1-2-9-5-8-4-6(9)3-7-1;1-2-8-9-4-3-7-5-6(1)9;1-2-4-9-5-7-8-6(9)3-1;19*1-4(2)3;;;;/h3-9H,1-2H3;2*1-7H;1-6H,7H2;11*1-6H;1-5H,(H,8,9);2*1-5H;1-2,7H,3-5H2;1-5H;19*4H,1-3H3;4*1H4.
What are the key properties of 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine?
1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine has a molecular weight of 3744.58 g/mol, XLogP of 66.98, 1 rotatable bonds, 2 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 1,3-benzoxazole;cinnoline;imidazo[1,5-a]pyrazine;1H-indazole;1H-indene;isoquinoline;methane;nonadecakis(2-methylpropane);1,5-naphthyridine;bis(1,6-naphthyridine);1,7-naphthyridine;1,8-naphthyridine;2,6-naphthyridine;2,7-naphthyridine;phthalazine;3-propan-2-ylisoquinoline;quinazoline;quinoline;quinoxaline;4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine;[1,2,4]triazolo[4,3-a]pyridine is sourced from PubChem (CID 159760802), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).